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gene would be useful in the first screening of
oral facial clefts
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Background: Interferon Regulatory Factor 6 (IRF6) is a member of the IRF family of transcription factors. It has been
suggested to be an important contributor to orofacial development since mutations of the IRF6 gene has been
found in Van der Woude (VWS) and popliteal pterygium syndromes (PPS), two disorders that can present with
isolated cleft lip and palate. The association between IRF6 gene and cleft lip and palate has also been
independently replicated in many populations.
Methods: We screened a total of 155 Taiwanese patients with cleft lip with or without cleft palate (CL/P); 31
syndromic (including 19 VWS families), 44 non-syndromic families with at least two affected members, and 80 non-
syndromic patients through a combined targeted, polymerase chain reaction (PCR)-based mutation analysis for the
entire coding regions of IRF6 gene.
Results: We found 11 mutations in 57.89% (11/19) of the VWS patients and no IRF6 mutation in 44 of the non-
syndromic multiplex families and 80 non-syndromic oral cleft patients. In this IRF6 gene screening, five of these
mutations (c.290 A>G, p.Tyr97Cys; c.360-375 16 bp deletion, p.Gln120HisfsX24; c.411_412 insA, p.Glu136fsX3; c.871
A>C, p.Thr291Pro; c.969 G>A, and p.Trp323X) have not been reported in the literature previously. Exon deletion was
not detected in this series of IRF6 gene screening.
Conclusions: Our results confirm the crucial role of IRF6 in the VWS patients and further work is needed to explore
for its function in the non-syndromic oral cleft with vary clinical features.
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Orofacial clefts are common congenital malformations
which require long-term treatment and patient care.
They are usually classified as either cleft lip with or
without cleft palate (CL/P) or cleft palate only (CP),
based on differences in embryological development
[1,2]. Approximately 70% of cases of orofacial clefting
occur as isolated entities with no other apparent cog-
nitive or craniofacial structural abnormalities and
are commonly termed ‘isolated, non-syndromic CL/P
(NSCL/P)’; while many syndromic forms have simple* Correspondence: yhwc8876@gmail.com
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reproduction in any medium, provided the orMendelian patterns of inheritance and therefore are
amenable to disease gene identification [3-5]. Previous
genetic and epidemiological studies have indicated that
the causes of nonsyndromic CL/P are multifactorial,
with both genetic and environmental factors contribut-
ing to the phenotype [6-9].
Of the large number of candidate genes thought to
contribute to orofacial clefting, Interferon Regulatory
Factor 6 (IRF6) is the only gene that has shown a con-
vincing degree of consistency across studies [10,11].
Mutations in IRF6 were first identified in the autosomal
dominant van der Woude syndrome (VWS; OMIM
119300), which is traditionally recognized as a mono-
genic syndrome characterized by lip pits, clefting of
the primary or secondary palate, and hypodontia [12].
Van der Woude syndrome (VWS) is estimated as mostral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2% of all cases of cleft lip and palate, and has the most
closely similarities in phenotype with that of common
non-syndromic forms [13-15]. Up to date, at least 200
different mutations in the IRF6 gene have been de-
scribed with the majority being protein truncation muta-
tions (nonsense and frameshifts) or missense mutations
[16]. Given the overlapping phenotype of VWS with
isolated CL/P, in searching the gene for mutations, non-
pathogenic variants in IRF6 gene have also been found
to be significantly associated with nonsyndromic oral
clefting in many different populations and ethnic
groups [10,17-23].
In order to determine the contribution of mutations in
IRF6 to oral clefts in the Taiwanese population, we ap-
plied a combination of targeted, PCR-based experimen-
tal approaches (including polymerase chain reaction
(PCR), Denature High Performance Liquid Chromatog-
raphy (DHPLC), Multiplex ligation-dependent probe
amplification (MLPA), TOPO cloning and DNA se-
quence analysis) for a cohort of oral cleft patients from
Craniofacial center of Chang Gung Memorial Hospital.
Methods
Study subjects
All patients were clinically assessed by the plastic sur-
geon and diagnosis as CL/P or CP based on clinical
examination, medical records, and a detailed question-
naire through Chang Gung Craniofacial Center. A total
of 155 patients with CL/P were included (31 syndromic,
44 non-syndromic families with at least two affected
members, and 80 non-syndromic patients). Diagnostic
criteria for individuals to be considered affected with
VWS included CLP or CPO, and at least one affected in-
dividual in the family with an anomaly in the lower lip,
generally bilateral pits. Cases in this series (collected
from 1997-2011) were selected only from cleft patients,
thus VWS patients presenting only with lower lip pits
were not included. In addition to these families, a total
of 100 healthy volunteers with no family history of VWS
and cleft lip and/or cleft palate were recruited as a con-
trol group for genetic analysis. This study was approved
by Chang Gung Medical Foundation Institutional Re-
view Board (No. 98-2610C) and written informed con-
sent was obtained from all patients or their parents prior
to participation in this study.
Molecular genetics analysis
DNA extraction and PCR amplification
Genomic DNA from blood were prepared from all the
study subjects by standard proteinase K digestion and
phenol/chloroform extraction using PUREGENE DNA
purification kit from GENTRA (Minneapolis, Minn,
USA).The exon-intron structure and sequence for entire
IRF6 gene were assessed from the National Center for
Biotechnology Information (NCBI) web site and pub-
lished literature. The oligonucleotide primers for amp-
lification of each exon and adjacent splice sites and at
least 40 bp upstream of the acceptor splice sites and
least 40 bp downstream of donor sites were designed
with Primer3 (http://frodo.wi.mit.edu/primer3/input.
htm). PCR amplification was performed using an auto-
mated thermocycler 9600/9700 (Applied Biosystem) in
a final volume of 25 ul containing 25 ng of template
DNA, 2.5 ul 10× reaction buffer(Sigma), 0.8 ul 25 mM
of dNTP, 5 ng of each of the primers and 0.25 units of
Taq polymerase. The amplification conditions were ad-
justed to the best condition for each exon and were: de-
naturation at 94°C for 2 minutes; 30 cycles each at
94°C for 30 seconds, 56°C or 60°C for 30 seconds, and
72°C for 30 seconds; and 72°C for 5 minutes.Mutation detection using denature high performance liquid
chromatography
PCR products were denatured and reannealed prior to
DHPLC analysis using a PCR program of briefly heating
to 95°C for 5 min followed by slow cooling to 25°C at a
rate of 1°C every 30s. The products were then run on a
WAVE-3500 Transgenomic WAVE™ machine equipped
with a DNASep column and WAVE Optimized™ Buffer
(Transgenomic Inc., Crewe, UK). The oven tempera-
tures for optimal heteroduplex separation were resolved
with Navigator v1.5.2 software, which gives a computer-
assisted determination of melting profile and analytical
conditions for each fragment. Wild-type DHPLC elution
profiles were characterized for each exon fragment by
analyzing at least two normal control DNA samples.Dissection of genomic rearrangement for candidate genes
using MLPA
Multiplex ligation-dependent probe amplification (MLPA)
was performed with 100 ng of genomic DNA according
to manufacturer’s instructions using the SALSA MLPA
KIT P304-A1 IRF6 (MRC-Holland, Amsterdam, the
Netherlands). This MLPA assay was designed to detect de-
letions/duplications of one or more exons of the IRF6
gene. Probe amplification products were run on an ABI
3730 DNA Analyzer using GS500 size standard (Applied
Biosystems). MLPA peak plots were visualized using
Genemapper Software version 3.7 (Applied Biosystems).
Non-normalized values for peak height and peak area
were then exported from Genemapper Software version
3.7 to an Excel template. Normalization of data and calcu-
lation of dosage ratios were performed as described at
www.mlpa.com.
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We performed TOPO TA cloning to distinguish allelic
status of PCR products with aberrant DNA sequence.
This strategy allows PCR inserts to ligate efficiently
with the topoisomerase I-bound vector (Invitrogen, CA,
USA). At least 10 colonies were selected and analyzed
by restriction enzyme-EcoRI to confirm the presence of
the insert. Finally, plasmids were further confirmed by
sequencing using ABI prism 3730 automated DNA Se-
quencer (Applied Biosystems). Sequence was analyzed
using Sequencing Analysis 5.2 software. Autoassembler
computer program (Applied Biosystems) was used for
sequence alignments and analysis. DNA sequence vari-
ants were confirmed by sequencing the opposite strand
of the PCR product. Mutations and polymorphisms were
sequenced in 96 control chromosomes from ethnically
matched, unaffected individuals.
Results
We screened a total of 155 patients with CL/P; 31 syn-
dromic, 44 non-syndromic families with at least two
affected members, and 80 non-syndromic patients
through a procedure of mutation analysis for the entire
PCR-amplified protein coding regions of IRF6. Eleven
different mutations occurring in exons 3, 4, 5, and 7 of
IRF6 gene were identified in the VWS patients (11/19,
57.89%). (Table 1) None was detected in 44 of the non-
syndromic multiplex families and 80 non-syndromicTable 1 IRF6 mutations identified in VWS patients
Pt no. SEX Family history Cleft type Exon
VWS-1 M positive BCLP 7
VWS-2 F negative BCLP 4
VWS-3 F negative RCLP –
VWS-4 F negative BCLP 5
VWS-5 M negative BCL 3 + 4
VWS-6 M positive BCLP 7
VWS-7 M negative RCLP –
VWS-8 F negative BCLP 4
VWS-9 F negative BCLP 4
VWS-N9 M positive BCLP, incomplete 4
VWS-11 F negative BCLP 4
VWS-12 M negative BCLP –
VWS-N90 F positive BCLP 4
VWS-14 F negative LCL –
VWS-15 M negative BCLP –
VWS-N93 M negative LCLP 3
VWS-N98 F positive LCLP –
old pt M positive LCLP 5
194 M negative BCLP 7oral cleft patients. Seven mutations (p.Ala16Val, p.Trp28X,
p.Arg84Cys, p.Arg84His, p.Lys89Glu, p.Tyr97Cys, and
p.Gln120HisfsX24) affected the DNA-binding domain,
which is involved in DNA interactions. Three mutations
(p.Thr291Pro, p.Trp323X, and p.Cys347Phe) were found
in the Smad-interferon regulatory factor-binding domain
that is critical for both homo- and hetero-dimerization of
IRF6 protein. There were one mutations (p.Lys137fsX3)
detected downstream of the DNA-binding domain. In
the present study, all affected members were heterozy-
gous for their respective mutation and five of these mu-
tations (p.Tyr97Cys, p.Gln120HisfsX24, p.Glu136fsX3,
p.Thr291Pro, and p.Trp323X) have not been reported in
the literature previously (Additional file 1: Figure S1). We
also apply the multiplex ligation-dependent probe amplifi-
cation technique (MLPA) to test for single/multiple exon
deletions/duplication within the IRF6 gene. However,
there were no such mutations detected in this study. For
those multiplex families, mutations detected in VWS-1,
VWS -6, VWS -N9, and VWS-N90 are all cosegrega-
ted with their affected members in the family (data
not shown).
Discussion
We have identified 11 different IRF6 mutations in VWS
patients and none in 44 of the non-syndromic multiplex
families and 80 non-syndromic oral cleft patients. In the
present study, all affected members were heterozygousIRF6 mutation aa changed Lip pit/nodules
c. 1040 G>T p. Cys347Phe 2 pits
c. 265 A>G p. Lys89Glu 2 pits
– – 2 asymmetric pits
c. 411_412 insA p. Lys137fsX3 2 pits
c. 47 C>T, c. 290 A>G p.Ala16Val, p.Tyr97Cys 2 pits
c. 969 G>A p. Trp323X 2 pits
– – 2 pits
c. 250 C>T p. Arg84Cys 2 pits
c. 333 T>C p. Tyr111Tyr 2 pits
c. 251 G>A p. Arg84His 2 pits
c. 251 G>A p. Arg84His 2 pits
– – 2 pits
c. 360-375 16 bp del p. Gln120HisfsX24 2 pits
– – 2 asymmetric pits
– – 2 pits
c. 83 G>A p. Trp28X 2 pits
– – 2 asymmetric pits
c.411 G>A p. Lys137Lys 2 pits
c.871 A>C p. Thr291Pro 2 pits
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tions (p.Tyr97Cys, p.Gln120HisfsX24, p.Glu136fsX3,
p.Thr291Pro, and p.Trp323X) have not been reported in
the literature previously.
Interferon Regulatory Factor 6 (IRF6) is a member of
transcription factors that contain a highly conserved
helix-turn-helix DNA-binding domain and a less con-
served SMAD-IRF-binding domain [12]. It has been
suggested to be important contributor to orofacial de-
velopment since mutations of the IRF6 gene have been
found in Van der Woude (VWS) and popliteal pteryg-
ium syndromes (PPS), two disorders that can clinically
resemble an isolated cleft lip and palate [12]. They were
detected in approximately 70% of VWS and 97% of PPS
cases [16]. Microdeletion of 1q32–q41 is relatively rare,
and only a few cases have been reported in the medical
literature [24-26]. While the majority of the VWS muta-
tions were spread over exons 3, 4, 7, 8 and 9, the major-
ity of PPS mutations were concentrated in exons 3 and
4 [16,27]. Basically, our results support a non-random
distribution of IRF6 mutations in VWS. More recently,
patients with nonsyndromic oral clefts have also been
reported to have IRF6 mutation [27-30]. Two authors
have observed IRF6 mutations among families with
mixed cleft phenotype, but they were unable to exclude
VWS completely [28,29]. Therefore, molecular differen-
tiation between these overlapping cleft syndromes is
absolutely essential before counseling can be given to
family members.
The incidence of VWS among cleft patients in our
population is 0.73 to 0.98 per 100,000, which is lower
than those reported from other studies [31]. The result
of IRF6 mutation screening for our VWS is also low
(57.89%). All these VWS cases were selected from cleft
patients, thus VWS patients presenting only with lower
lip pits were not included. The patients in our series had
more severe types of cleft, with a higher incidence of bi-
lateral complete cleft lip and palate than given in other
reports. The size, shape, and depth of the pits varied
among patients beyond oral cleft phenotypes. The asso-
ciated anomalies found in our series included heman-
gioma, hypertelorism, syngnathism, protruding ears,
ventricular septal defect, toe and foot anomaly, and un-
descended testis. All the differences in the distribution
of the different types of cleft, the penetrance, and famil-
ial occurrence between our study and other reports may
be explained by ethnic and/or nongenetic environmental
factors.
Lip and palate formations are the consequence of a
complex processes that involves cell proliferation, cell dif-
ferentiation, cell adhesion, and apoptosis. In theory, failure
anywhere in these processes can lead to clefts [2,32]. We
hypothesize that IRF6 may play different roles in combin-
ation with other genetic and/or environmental factorsduring the embryonic development [33,34]. Information
regarding the profile of gene-gene or gene-environment
interaction or network for the craniofacial development
should also be considered. Meta analysis of mutation-
proved IRF6-related phenotypes might provide another
useful indicator for the diagnosis of orofacial cleft in the
near future.
Conclusions
This is one of the largest single reports of IRF6 mutation
screens applying a combined targeted mutation analysis.
Our results confirm the crucial role of IRF6 in the VWS
patients and further work is needed to explore for its
function in the non-syndromic oral cleft with vary clin-
ical features.
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